Limeway Pharma Design is a dermatology-focused biopharmaceutical design company specialising in advanced topical delivery technologies that achieve clinically meaningful skin exposure while minimising systemic risk.
Our platform is protected by two granted international patent families and designed to overcome the historical limitations of topical therapy: poor penetration, irritation, unwanted systemic delivery, cosmetic unacceptability, and poor adherence.
Local precision therapy for skin biology driven by cumulative UV damage
Patented delivery platform
Protected glycol-in-silicone co-enhancer technology with global patent coverage.
Local precision
High, sustained epidermal exposure without unnecessary systemic exposure.
Biology-led design
Built around NAD⁺ restoration, DNA repair, and barrier recovery.
Adherence-first
Pharmaceutical efficacy combined with cosmetic-grade experience.